Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database.

CONCLUSION: Underutilization of trimodality therapy negatively impacted survival for patients with IBC. The use of trimodality therapy increased marginally with time, but there remain significant factors associated with differences in use of trimodality treatment. We have identified specific barriers to care that may be targeted to improve treatment delivery and potentially improve patient outcomes. PMID: 24888808 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24888808?dopt=Abstract

Source: Clinical Breast Cancer - June 2, 2014 Category: Cancer & Oncology Authors: Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera G Tags: J Clin Oncol Source Type: research